Niagen Bioscience
NAGE
50 hedge funds and large institutions have $13M invested in Niagen Bioscience in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
23% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 13
4% more funds holding
Funds holding: 48 → 50 (+2)
21% less capital invested
Capital invested by funds: $16.5M → $13M (-$3.45M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
+$997K |
| 2 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$532K |
| 3 |
State Street
Boston,
Massachusetts
|
+$395K |
| 4 |
SCM
Silver Capital Management
New York
|
+$162K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$118K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Coe Capital Management
Highland Park,
Illinois
|
-$683K |
| 2 |
Goldman Sachs
New York
|
-$478K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$93.3K |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
-$88.9K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$45.6K |
NAGE Hedge Fund Activity: Q3 2016 in Review
50 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q3 2016, worth a combined $13M — down 21% from $16.5M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new NAGE positions and 4 closed out — a net gain of 2 holders — while 16 added to existing stakes and 13 trimmed.
The largest buyer was North Star Investment Management, opening a new position worth an estimated $997K. The largest seller was Coe Capital Management, exiting entirely with an estimated $683K sold.
- 50 institutional investors held Niagen Bioscience (NAGE) as of Q3 2016, up from 48 in Q2 2016.
- Funds reported $13M of Niagen Bioscience stock for Q3 2016, down 21% quarter-over-quarter.
- 6 funds opened new Niagen Bioscience positions in Q3 2016 and 4 closed out, a net change of +2 holders.
- The largest Niagen Bioscience buyer in Q3 2016 was North Star Investment Management, an estimated $997K added.
- The largest Niagen Bioscience seller in Q3 2016 was Coe Capital Management, an estimated $683K sold.
Based on aggregated 13F filings for Q3 2016.